PL1810676T3 - Formulacje lewetiracetamu i sposoby ich wytwarzania - Google Patents
Formulacje lewetiracetamu i sposoby ich wytwarzaniaInfo
- Publication number
- PL1810676T3 PL1810676T3 PL06251210T PL06251210T PL1810676T3 PL 1810676 T3 PL1810676 T3 PL 1810676T3 PL 06251210 T PL06251210 T PL 06251210T PL 06251210 T PL06251210 T PL 06251210T PL 1810676 T3 PL1810676 T3 PL 1810676T3
- Authority
- PL
- Poland
- Prior art keywords
- methods
- manufacture
- levetiracetam
- compositions
- formulations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US76210306P | 2006-01-24 | 2006-01-24 | |
EP06251210A EP1810676B1 (en) | 2006-01-24 | 2006-03-07 | Levetiracetam formulations and methods for their manufacture |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1810676T3 true PL1810676T3 (pl) | 2009-04-30 |
Family
ID=36337638
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL06251210T PL1810676T3 (pl) | 2006-01-24 | 2006-03-07 | Formulacje lewetiracetamu i sposoby ich wytwarzania |
Country Status (13)
Country | Link |
---|---|
US (1) | US20070172521A1 (pl) |
EP (1) | EP1810676B1 (pl) |
JP (1) | JP2009524658A (pl) |
CN (1) | CN101360493A (pl) |
AT (1) | ATE413875T1 (pl) |
CA (1) | CA2637925A1 (pl) |
DE (1) | DE602006003617D1 (pl) |
DK (1) | DK1810676T3 (pl) |
ES (1) | ES2317452T3 (pl) |
IL (1) | IL193024A0 (pl) |
PL (1) | PL1810676T3 (pl) |
PT (1) | PT1810676E (pl) |
WO (1) | WO2007086891A1 (pl) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2696977C (en) | 2007-10-16 | 2012-12-04 | Pharmathen S.A. | Improved pharmaceutical composition containing a pyrrolidone anticonvulsant agent and method for the preparation thereof |
US20120003307A1 (en) * | 2007-11-29 | 2012-01-05 | Ranbaxy Laboratories Limited | Levetiracetam controlled release composition |
WO2009135646A2 (en) * | 2008-05-05 | 2009-11-12 | Farmaprojects, Sa | Stable pharmaceutical compositions and their processes for preparation suitable for industrial scale |
US20100172979A1 (en) * | 2008-12-24 | 2010-07-08 | Zhongshui Yu | Controlled-release formulations |
US20100159009A1 (en) * | 2008-12-24 | 2010-06-24 | Zhongshui Yu | Controlled-release formulations |
MX336663B (es) | 2009-09-18 | 2016-01-27 | Sanofi Sa | Formulaciones en comprimido de la (4'-trifluorometilfenil)amida del acido (z)-2-ciano-3-hidroxibut-2-enoico con estabilidad mejorada. |
CN101693017B (zh) * | 2009-10-28 | 2012-06-06 | 北京赛科药业有限责任公司 | 左乙拉西坦的药物组合物及其制备方法 |
EP2563340A2 (en) | 2010-04-26 | 2013-03-06 | Mahmut Bilgic | Water soluble pharmaceutical composition |
US8906949B2 (en) * | 2010-05-21 | 2014-12-09 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Orally disintegrating tablets of zolmitriptan and process for preparing the same |
CN102379857B (zh) * | 2011-05-30 | 2013-10-09 | 深圳信立泰药业股份有限公司 | 一种左乙拉西坦缓释药物组合物及其制备方法 |
CN102764254B (zh) * | 2012-05-16 | 2016-09-07 | 深圳信立泰药业股份有限公司 | 一种左乙拉西坦药物组合物及其制备方法 |
JP6630229B2 (ja) * | 2016-05-17 | 2020-01-15 | エルメッド株式会社 | レベチラセタム含有医薬組成物及びその製造方法 |
JP6422464B2 (ja) * | 2016-05-19 | 2018-11-14 | エルメッド エーザイ株式会社 | レベチラセタム含有医薬組成物及びその製造方法、並びにレベチラセタム含有医薬組成物の崩壊及び溶出の少なくともいずれかの遅延防止方法、及びレベチラセタム含有医薬組成物の崩壊及び溶出の少なくともいずれかの遅延防止剤 |
JP6326114B2 (ja) * | 2016-11-01 | 2018-05-16 | エルメッド エーザイ株式会社 | レベチラセタム含有医薬組成物及びその製造方法、並びにレベチラセタム含有医薬組成物の崩壊及び溶出の少なくともいずれかの遅延防止方法、及びレベチラセタム含有医薬組成物の崩壊及び溶出の少なくともいずれかの遅延防止剤 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4514389A (en) * | 1981-05-06 | 1985-04-30 | Kyowa Chemical Industry Co. Ltd. | Gastric antacid and method for controlling pH of gastric juice |
GB8412357D0 (en) * | 1984-05-15 | 1984-06-20 | Ucb Sa | Pharmaceutical composition |
GB9319732D0 (en) * | 1993-09-24 | 1993-11-10 | Ucb Sa | Use of (s)-alpha-ethyl-2-oxo-l-pyrrolidineacetamide for the treatment of anxiety |
EP1600169A3 (en) * | 1999-12-01 | 2009-09-23 | Ucb, S.A. | A pyrrolidineacetamide derivative alone or in combination for treatment of CNS disorders |
US20040116506A1 (en) * | 2002-06-20 | 2004-06-17 | Krusz John Claude | Use of levetiracetam for treating or preventing acute headaches |
CN1205938C (zh) * | 2002-10-08 | 2005-06-15 | 深圳海王药业有限公司 | 具有改善哺乳动物微循环作用的产品 |
US7132552B2 (en) * | 2003-02-03 | 2006-11-07 | Teva Pharmaceutical Industries, Ltd. | Process for producing levetiracetam |
AU2003217438A1 (en) * | 2003-03-18 | 2004-10-11 | Hetero Drugs Limited | Novel crystalline forms of levetiracetam |
WO2005023763A1 (en) * | 2003-09-05 | 2005-03-17 | Ranbaxy Laboratories Limited | Process for the preparation of pure levetiracetam |
MX2007004294A (es) * | 2005-07-26 | 2008-03-11 | Ucb Pharma Sa | Composiciones farmaceuticas que comprenden levetiracetam y proceso para su preparacion. |
-
2006
- 2006-03-07 PT PT06251210T patent/PT1810676E/pt unknown
- 2006-03-07 DK DK06251210T patent/DK1810676T3/da active
- 2006-03-07 EP EP06251210A patent/EP1810676B1/en not_active Revoked
- 2006-03-07 PL PL06251210T patent/PL1810676T3/pl unknown
- 2006-03-07 DE DE602006003617T patent/DE602006003617D1/de active Active
- 2006-03-07 ES ES06251210T patent/ES2317452T3/es active Active
- 2006-03-07 AT AT06251210T patent/ATE413875T1/de not_active IP Right Cessation
- 2006-03-07 US US11/371,128 patent/US20070172521A1/en not_active Abandoned
- 2006-03-07 CA CA002637925A patent/CA2637925A1/en not_active Abandoned
- 2006-03-07 JP JP2008552284A patent/JP2009524658A/ja active Pending
- 2006-03-07 WO PCT/US2006/008298 patent/WO2007086891A1/en active Application Filing
- 2006-03-07 CN CNA2006800516061A patent/CN101360493A/zh active Pending
-
2008
- 2008-07-24 IL IL193024A patent/IL193024A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
PT1810676E (pt) | 2009-01-02 |
CN101360493A (zh) | 2009-02-04 |
ATE413875T1 (de) | 2008-11-15 |
US20070172521A1 (en) | 2007-07-26 |
EP1810676A1 (en) | 2007-07-25 |
DE602006003617D1 (de) | 2008-12-24 |
EP1810676B1 (en) | 2008-11-12 |
WO2007086891A1 (en) | 2007-08-02 |
CA2637925A1 (en) | 2007-08-02 |
JP2009524658A (ja) | 2009-07-02 |
ES2317452T3 (es) | 2009-04-16 |
DK1810676T3 (da) | 2009-02-09 |
IL193024A0 (en) | 2009-02-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL193024A0 (en) | Levetiracetam formulations and methods for their manufacture | |
NO20092611L (no) | Krystallinsk faststoff Rasagilin base | |
PH12014502880A1 (en) | Lyophilized therapeutic peptibody formulations | |
EP2535058A3 (en) | Stabilization of vaccines by lyophilization | |
WO2007146965A3 (en) | Compounds for the treatment of periodontal disease | |
EP1962838A4 (en) | Farnesoid X RECEPTOR AGONISTS | |
GEP20094784B (en) | Sustained release pharmaceutical formulations | |
HK1104795A1 (en) | Dry formulations of aripiprazole | |
TW200738659A (en) | Novel compounds | |
TW200730518A (en) | Crystalline forms of docetaxel and processes for their preparation | |
WO2007106746A3 (en) | Formulations for ecallantide | |
TW200800967A (en) | Benzimidazole thiophene compounds | |
IL186127A (en) | Subcutaneous preparations for the treatment of depression and methods for their preparation | |
TW200738649A (en) | Calcilytic compounds | |
IL190774A0 (en) | Pharmaceutical compositions containing a jorumycin-renieramycin-or saframycin-related compounds for treating proliferative diseases | |
WO2006091836A8 (en) | Formulations of ladostigil tartrate | |
TW200718698A (en) | Process for preparing new tiotropium salts, new tiotropium salts as such and pharmaceutical compositions thereof | |
PL1707564T3 (pl) | Pochodne indanylopiperazyn, sposób ich wytwarzania i zawierające je kompozycje farmaceutyczne | |
HUP0401523A2 (en) | Indole-2-carboxamide derivatives, pharmaceutical compositions containing them and process for producing them | |
TW200638932A (en) | CCI-779 polymorph and use thereof | |
TNSN07241A1 (en) | Substituted pyrroles, compositions containing same, method for making same and use thereof | |
HK1126190A1 (en) | Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them | |
WO2007071444A3 (en) | Esomeprazole arginine | |
EP1991248A4 (en) | ANTIDEPRESSANT PRODRUGS | |
UA88182C2 (ru) | Композиция, которая содержит эпотилон (варианты), и способ ее получения (варианты) |